BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38565642)

  • 1. The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities.
    Huang R; Bornman MSR; Stricker PD; Simoni Brum I; Mutambirwa SBA; Jaratlerdsiri W; Hayes VM
    Sci Rep; 2024 Apr; 14(1):7706. PubMed ID: 38565642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
    Pellatt AJ; Wolff RK; Torres-Mejia G; John EM; Herrick JS; Lundgreen A; Baumgartner KB; Giuliano AR; Hines LM; Fejerman L; Cawthon R; Slattery ML
    Genes Chromosomes Cancer; 2013 Jul; 52(7):595-609. PubMed ID: 23629941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The telomere length landscape of prostate cancer.
    Livingstone J; Shiah YJ; Yamaguchi TN; Heisler LE; Huang V; Lesurf R; Gebo T; Carlin B; Eng S; Drysdale E; Green J; van der Kwast T; Bristow RG; Fraser M; Boutros PC
    Nat Commun; 2021 Nov; 12(1):6893. PubMed ID: 34824250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of telomere length in risk and recurrence of prostate cancer: A meta-analysis.
    Hu R; Hua XG; Jiang QC
    Andrologia; 2019 Aug; 51(7):e13304. PubMed ID: 31090230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies.
    Joshua AM; Shen E; Yoshimoto M; Marrano P; Zielenska M; Evans AJ; Van der Kwast T; Squire JA
    Prostate; 2011 May; 71(7):778-90. PubMed ID: 21031437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers.
    Gong T; Jaratlerdsiri W; Jiang J; Willet C; Chew T; Patrick SM; Lyons RJ; Haynes AM; Pasqualim G; Brum IS; Stricker PD; Mutambirwa SBA; Sadsad R; Papenfuss AT; Bornman RMS; Chan EKF; Hayes VM
    Genome Med; 2022 Aug; 14(1):100. PubMed ID: 36045381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
    Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
    EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread telomere instability in prostatic lesions.
    Tu L; Huda N; Grimes BR; Slee RB; Bates AM; Cheng L; Gilley D
    Mol Carcinog; 2016 May; 55(5):842-52. PubMed ID: 25917938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis.
    Kroupa M; Rachakonda SK; Liska V; Srinivas N; Urbanova M; Jiraskova K; Schneiderova M; Vycital O; Vymetalkova V; Vodickova L; Kumar R; Vodicka P
    Br J Cancer; 2019 Aug; 121(4):344-350. PubMed ID: 31312029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
    Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study examining the relationship between chronic heroin use and telomere length among individuals of African ancestry.
    Martinez S; Jones JD
    Pharmacol Biochem Behav; 2023 Oct; 231():173631. PubMed ID: 37689117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
    Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
    J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
    Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
    BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
    Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
    Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
    Liu Z; Guo H; Zhu Y; Xia Y; Cui J; Shi K; Fan Y; Shi B; Chen S
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):482-491. PubMed ID: 33214693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of telomere length in primary and metastatic colorectal cancer lesions.
    Kroupa M; Kubecek O; Tomasova K; Hanak P; Krupova M; Cervena K; Siskova A; Rosendorf J; Hosek P; Vodickova L; Vodicka P; Liska V; John S; Vymetalkova V; Petera J
    Sci Rep; 2023 Jun; 13(1):9097. PubMed ID: 37277368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
    Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
    Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic-tumour heterogeneity and instability.
    Mehdipour P; Kheirollahi M; Mehrazin M; Kamalian N; Atri M
    Cell Biol Int; 2011 Sep; 35(9):915-25. PubMed ID: 21385157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Determinants of Telomere Length in African American Youth.
    Zeiger AM; White MJ; Eng C; Oh SS; Witonsky J; Goddard PC; Contreras MG; Elhawary JR; Hu D; Mak ACY; Lee EY; Keys KL; Samedy LA; Risse-Adams O; Magaña J; Huntsman S; Salazar S; Davis A; Meade K; Brigino-Buenaventura E; LeNoir MA; Farber HJ; Bibbins-Domingo K; Borrell LN; Burchard EG
    Sci Rep; 2018 Sep; 8(1):13265. PubMed ID: 30185882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.